Halozyme Therapeutics logo
Halozyme Therapeutics HALO
€ 54.46 -1.27%

Geschäftsbericht 2025
hinzugefügt 17.02.2026

report update icon

Halozyme Therapeutics DSO 2011-2026 | HALO

DSO Jährlich Halozyme Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
93.4 93.7 51.3 - 40.2 107 111 72.1 25.5 39 87.6 44.3 60.6 135 14.7

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
135 14.7 69.7

DSO Vierteljährlich Halozyme Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
84.8 86.7 102 - 76 78 97.5 - 92 86 107 - 92.3 90.8 79.7 - 104 80.8 95.4 73.3 137 161 283 101 117 139 71.7 45.5 107 77.8 77 10.7 31.7 59.8 58.4 36.7 44.9 42.9 51.6 75.8 142 68.2 102 27.5 57.2 45.4 69.6 66.4 51.8 57.4 95.6 65.8 269 185 110 85.6 9 8.9 -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
283 8.9 86.5

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
20.6 $ 0.88 -1.73 % $ 6.47 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
37.5 $ 22.76 2.06 % $ 3.77 B usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
87.4 - - $ 35.4 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
24.7 - -0.88 % $ 598 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
59 - 17.91 % $ 11.1 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.07 -0.73 % $ 435 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 23.28 -0.62 % $ 2.96 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.47 3.52 % $ 391 M britainBritain
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 2.91 -0.34 % $ 4.79 M israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
2.47 - - $ 546 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Cardiff Oncology Cardiff Oncology
CRDF
294 $ 1.68 -2.33 % $ 112 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
52.1 - - $ 1.2 B usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
103 $ 1.06 -2.75 % $ 12.9 M usaUSA